Acceleron
https://www.acceleronpharma.com/Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics. Acceleron went public in September 2013 (NASDAQ: XLRN).
Location: United States, Cambridge
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | Bessemer V... | bvp.com |
| - | Lightstone... | lightstone... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 23.12.2011 | - | $30M | - | Acceleron ... |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 29.03.2019 | Shares of bluebird on the Nasd... | - | - | medcitynew... | |
| 20.03.2019 | Flagship P... | “With each year of company o... | - | - | medcitynew... |
| 26.03.2015 | Flagship V... | The company’s previous fund ... | - | - | medcitynew... |
| 01.11.2013 | OrbiMed cl... | Looking back 5 to 6 years, hea... | - | - | medcitynew... |
| 20.01.2012 | Boston’s... | Share Share on Facebook Share ... | - | Gregory T.... | xconomy.co... |
| 23.12.2011 | Acceleron ... | Acceleron Pharma, Inc., a Camb... | funding U... | - | finsmes.co... |
| 30.10.2007 | Life scien... | Featured companies: Acceleron ... | - | - | venturebea... |
| 19.09.2007 | Life scien... | Featured companies: Acceleron ... | - | - | venturebea... |